[In vivo gene editing for gene therapy]

Area of Science:

• Biotechnology
• Genetics
• Clinical Medicine

Background:

• Gene editing technologies offer potential therapeutic strategies.
• Targeting pathogenic proteins is crucial for treating genetic diseases.

Purpose of the Study:

• To evaluate the safety and efficacy of in vivo gene editing in a clinical setting.
• To assess the impact of gene editing on pathogenic protein levels.

Main Methods:

• Phase I clinical trial.
• In vivo gene editing administration.
• Measurement of pathogenic protein levels.

Main Results:

• Successful in vivo gene editing was achieved in human participants.
• A significant reduction in the target pathogenic protein was observed.

Conclusions:

• Preliminary results demonstrate the feasibility of in vivo gene editing in humans.
• This approach shows potential for developing novel gene therapies.